Sustaining neovascularization of a scaffold through staged release of vascular endothelial growth factor-a and platelet-derived growth factor-BB

Tissue Engineering - Part A

Volumn 18, Issue 1-2, 2012, Pages 26-34

  Davies, Neil H ^a   Schmidt, Christian ^a,b   Bezuidenhout, Deon ^a   Zilla, Peter ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; PEPTIDES; PLATELETS; POLYSACCHARIDES; TISSUE;

COVALENT MODIFICATIONS; COVALENTLY BOUND; GROWTH FACTOR; IN-VITRO; IN-VIVO; NEOVASCULARIZATION; PDGF BB'S; PLATELET-DERIVED GROWTH FACTORS; POROUS SCAFFOLD; SUBCUTANEOUS IMPLANTS; SURFACE COATINGS; THREE-DIMENSIONAL SCAFFOLDS; TIME POINTS; TISSUE REGENERATION; VASCULAR ENDOTHELIAL GROWTH; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION;

SCAFFOLDS (BIOLOGY);

RATTUS;

HEPARIN; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; PLATELET-DERIVED GROWTH FACTOR BB; POLYURETHAN; TISSUE SCAFFOLD; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ARTERY; ARTICLE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMPLANTATION; KINETICS; POROSITY; RAT; SCANNING ELECTRON MICROSCOPY; SECRETION; SUBCUTANEOUS TISSUE; WISTAR RAT;

ANIMALS; ARTERIES; HEPARIN; HUMANS; KINETICS; MICROSCOPY, ELECTRON, SCANNING; NEOVASCULARIZATION, PHYSIOLOGIC; POLYURETHANES; POROSITY; PROSTHESIS IMPLANTATION; PROTO-ONCOGENE PROTEINS C-SIS; RATS; RATS, WISTAR; SUBCUTANEOUS TISSUE; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84855393083     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0192     Document Type: Article

References (37)

1. Mikos, A.G., Herring, S.W., Ochareon, P., Elisseeff, J., Lu, H.H., Kandel, R., et al. Engineering complex tissues. Tissue Eng 12, 3307, 2006.
2. Tayalia, P., and Mooney, D.J. Controlled growth factor delivery for tissue engineering. Adv Mater 21, 3269, 2009.
3. Baluk, P., Lee, C.G., Link, H., Ator, E., Haskell, A., Elias, J.A., et al. Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways. Am J Pathol 165, 1071, 2004.
4. Davies, N., Dobner, S., Bezuidenhout, D., Schmidt, C., Beck, M., Zisch, A.H., et al. The dosage dependence of VEGF stimulation on scaffold neovascularisation. Biomaterials 29, 3531, 2008.
5. Zisch, A.H., Lutolf, M.P., and Hubbell, J.A. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol 12, 295, 2003.
6. Lazarous, D.F., Shou, M., Scheinowitz, M., Hodge, E., Thirumurti, V., Kitsiou, A.N., et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 94, 1074, 1996.
7. Whalen, G.F., Shing, Y., and Folkman, J. The fate of intravenously administered bFGF and the effect of heparin. Growth Factors 1, 157, 1989.
8. Simons, M., Bonow, R., Chronos, N., Cohen, D., Giordano, F., Hammond, H., et al. Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation 102, E73, 2000.
9. Cao, R., Brakenhielm, E., Pawliuk, R., Wariaro, D., Post, M.J., Wahlberg, E., et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9, 604, 2003.
10. Yancopoulos, G., Davis, S., Gale, N., Rudge, J., Wiegand, S., and Holash, J. Vascular-specific growth factors and blood vessel formation. Nature 407, 242, 2000.
11. Richardson, T., Peters, M., Ennett, A., and Mooney, D. Polymeric system for dual growth factor delivery. Nat Biotechnol 19, 1029, 2001.
12. Taipale, J., and Keski-Oja, J. Growth factors in the extracellular matrix. FASEB J 11, 51, 1997.
13. Nillesen, S.T., Geutjes, P.J., Wismans, R., Schalkwijk, J., Daamen, W.F., and van Kuppevelt, T.H. Increased angiogenesis in acellular scaffolds by combined release of FGF2 and VEGF. J Control Release 116, e88, 2006.
14. Steffens, G.C., Yao, C., Prevel, P., Markowicz, M., Schenck, P., Noah, E.M., et al. Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor. Tissue Eng 10, 1502, 2004.
15. Sun, B., Chen, B., Zhao, Y., Sun, W., Chen, K., Zhang, J., et al. Crosslinking heparin to collagen scaffolds for the delivery of human platelet-derived growth factor. J Biomed Mater Res B Appl Biomater 91, 366, 2009.
16. Bezuidenhout, D., Davies, N., Black, M., Schmidt, C., Oosthuysen, A., and Zilla, P. Covalent surface heparinization potentiates porous polyurethane scaffold vascularization. J Biomater Appl 24, 401, 2010.
17. Bezuidenhout, D., Davies, N., and Zilla, P. Effect of well defined dodecahedral porosity on inflammation and angiogenesis. ASAIO J 48, 465, 2002.
18. Schmidt, C., Bezuidenhout, D., Beck, M., Van der Merwe, E., Zilla, P., and Davies, N. Rapid three-dimensional quantification of VEGF-induced scaffold neovascularisation by microcomputed tomography. Biomaterials 30, 5959, 2009.
19. Schmidt, C., Bezuidenhout, D., Higham, L., Zilla, P., and Davies, N. Induced Chronic Hypoxia negates the proangiogenic effect of surface immobilized heparin in a polyurethane porous scaffold. J Biomed Mater Res A 98, 621, 2011.
20. Beckstead, J. A simple technique for preservation of fixationsensitive antigens in paraffin-embedded tissues. J Histochem Cytochem 42, 1127, 1994.
21. Fujita, M., Ishihara, M., Simizu, M., Obara, K., Ishizuka, T., Saito, Y., et al. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. Biomaterials 25, 699, 2004.
22. Ishihara, M., Obara, K., Ishizuka, T., Fujita, M., Sato, M., Masuoka, K., et al. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J Biomed Mater Res 64A, 551, 2003.
23. Sakiyama-ES, and Hubbell, J. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release 65, 389, 2000.
24. Tanihara, M., Suzuki, Y., Yamamoto, E., Noguchi, A., and Mizushima, Y. Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. J Biomed Mater Res 56, 216, 2001.
25. Doi, K., and Matsuda, T. Enhanced vascularization in a microporous polyurethane graft impregnated with basic fibroblast growth factor and heparin. J Biomed Mater Res 34, 361, 1997.
26. Singer, A., and Clark, R. Cutaneous wound healing. N Engl J Med 341, 738, 1999.
27. Elcin, A.E., and Elcin, Y.M. Localized angiogenesis induced by human vascular endothelial growth factor-activated PLGA sponge. Tissue Eng 12, 959, 2006.
28. Benjamin, L., Hemo, I., and Keshet, E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125, 1591, 1998.
29. Hao, X., Mansson-Broberg, A., Blomberg, P., Dellgren, G., Siddiqui, A.J., Grinnemo, K.H., et al. Angiogenic and cardiac functional effects of dual gene transfer of VEGF-A165 and PDGF-BB after myocardial infarction. Biochem Biophys Res Commun 322, 292, 2004.
30. Battegay, E.J., Rupp, J., Iruela-Arispe, L., Sage, E.H., and Pech, M. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors. J Cell Biol 125, 917, 1994.
31. Heldin, C.H., and Westermark, B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79, 1283, 1999.
32. Sato, N., Beitz, J.G., Kato, J., Yamamoto, M., Clark, J.W., Calabresi, P., et al. Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol 142, 1119, 1993.
33. Guo, P., Hu, B., Gu, W., Xu, L., Wang, D., Huang, H.J., et al. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol 162, 1083, 2003.
34. Sufen, G., Xianghong, Y., Yongxia, C., and Qian, P. bFGF and PDGF-BB have a synergistic effect on the proliferation, migration and VEGF release of endothelial progenitor cells. Cell Biol Int 35, 545, 2011.
35. Matei, D., Kelich, S., Cao, L., Menning, N., Emerson, R.E., Rao, J., et al. PDGF BB induces VEGF secretion in ovarian cancer. Cancer Biol Ther 6, 1951, 2007.
36. Stavri, G.T., Hong, Y., Zachary, I.C., Breier, G., Baskerville, P.A., Yla-Herttuala, S., et al. Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Lett 358, 311, 1995.
37. Magnusson, P.U., Looman, C., Ahgren, A., Wu, Y., Claesson-Welsh, L., and Heuchel, R.L. Platelet-derived growth factor receptor-beta constitutive activity promotes angiogenesis in vivo and in vitro. Arterioscler Thromb Vasc Biol 27, 2142, 2007.